Common Stock, Shares, Outstanding of UroGen Pharma Ltd. from 31 Dec 2016 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
UroGen Pharma Ltd. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2016 to 31 Dec 2025.
  • UroGen Pharma Ltd. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 48,350,272, a 14% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

UroGen Pharma Ltd. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 48,350,272 +6,118,526 +14% 31 Dec 2025 10-K 02 Mar 2026 2025 FY
Q3 2025 46,781,211 +4,590,396 +11% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 46,199,134 +5,029,180 +12% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 46,101,785 +9,974,098 +28% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 42,231,746 +9,741,627 +30% 31 Dec 2024 10-K 02 Mar 2026 2025 FY
Q3 2024 42,190,815 -9,185 -0.02% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 41,169,954 +17,671,337 +75% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 36,127,687 +12,687,166 +54% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 32,490,119 +9,360,166 +40% 31 Dec 2023 10-K 10 Mar 2025 2024 FY
Q3 2023 42,200,000 +19,188,676 +83% 30 Sep 2023 10-Q 06 Nov 2024 2024 Q3
Q2 2023 23,498,617 +770,726 +3.4% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 23,440,521 +758,300 +3.3% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 23,129,953 +666,958 +3% 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 23,011,324 +606,479 +2.7% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 22,727,891 +373,358 +1.7% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 22,682,221 +401,827 +1.8% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 22,462,995 +295,204 +1.3% 31 Dec 2021 10-K 24 Mar 2023 2022 FY
Q3 2021 22,404,845 +333,413 +1.5% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 22,354,533 +353,237 +1.6% 30 Jun 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 22,280,394 +1,067,454 +5% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 22,167,791 +1,141,607 +5.4% 31 Dec 2020 10-K 21 Mar 2022 2021 FY
Q3 2020 22,071,432 +1,127,182 +5.4% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 22,001,296 +1,151,781 +5.5% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 21,212,940 +454,592 +2.2% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 21,026,184 +4,811,301 +30% 31 Dec 2019 10-K 18 Mar 2021 2020 FY
Q3 2019 20,944,250 +4,841,993 +30% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 20,849,515 +4,996,229 +32% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 20,758,348 +5,284,367 +34% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 16,214,883 +2,463,493 +18% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q3 2018 16,102,257 30 Sep 2018 6-K 13 Nov 2018 2018 Q3
Q2 2018 15,853,286 30 Jun 2018 6-K 14 Aug 2018 2018 Q2
Q1 2018 15,473,981 31 Mar 2018 6-K 15 May 2018 2018 Q1
Q4 2017 13,751,390 +11,445,647 +496% 31 Dec 2017 10-K 28 Feb 2019 2018 FY
Q4 2016 2,305,743 31 Dec 2016 20-F 15 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.